Search Results - "Karsten, T.M"

Achievements in colorectal cancer care during 8 years of auditing in The Netherlands by de Neree tot Babberich, Michael P.M., Detering, Robin, Dekker, Jan Willem T., Elferink, Marloes A., Tollenaar, Rob A.E.M., Wouters, Michel W.J.M., Tanis, Pieter J., Beets-Tan, R.G.H., Bemelman, W.A., Boerma, D., Coenen, P.P., Dekker, E., Eddes, E.H., Gelderblom, H., van der Harst, E., Karsten, T.M., van Krieken, J.H., van Leersum, N.J., Lemmens, V.E., Meijerink, W.J., Manusama, E.R., Marijnen, C.A.M., Nagtegaal, I.D., van de Velde, C.J., Wiggers, T.

“…The efficacy of auditing is still a subject of debate and concerns exist whether auditing promotes risk averse behaviour of physicians. This study evaluates…”
Get full text

Laparoscopic modified Blumgart pancreaticojejunostomy after pancreatoduodenectomy using a unidirectional barbed suture and an internal stent by Steen, M.W, de Rooij, T, Karsten, T.M, de Castro, S.M.M, Busch, O.R.C, Besselink, M.G.H, Festen, S, Gerhards, M.F

Get full text

Laparoscopic modified blumgart pancreaticojejunostomy using a unidirectional barbed suture after pancreatoduodenectomy by Festen, S, Steen, M.W, de Rooij, T, Busch, O.R, Karsten, T.M, Besselink, M.G, Gerhards, M.F

Get full text

LBA83 Neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): A multicenter randomized controlled trial by Groot Koerkamp, B., Janssen, Q.P., van Dam, J.L., Bonsing, B.A., Bos, H., Bosscha, K.P., Haberkorn, B.C.M., de Hingh, I.H.J.T., Karsten, T.M., Van der Kolk, M.B., Liem, M.S.L., Loosveld, O.J.L., Patijn, G.A., van Santvoort, H.C.M., J. de vos-Geelen, van der Holt, B., Homs, M.Y.V., van Tienhoven, G., Besselink, M.G., Wilmink, H.W.

Get full text

Three-Year Nationwide Experience with Transanal Total Mesorectal Excision for Rectal Cancer in the Netherlands: A Propensity Score-Matched Comparison with Conventional Laparoscopic Total Mesorectal Excision by Detering, Robin, Roodbeen, Sapho X., van Oostendorp, Stefan E., Dekker, Jan-Willem T., Sietses, Colin, Bemelman, Willem A., Tanis, Pieter J., Hompes, Roel, Tuynman, Jurriaan B., Aalbers, A.G.J., Beets-Tan, R.G.H., den Boer, F.C., Breukink, S.O., Coene, P.P.L.O., Doornebosch, P.G., Gelderblom, A.J., Karsten, T.M., Ledeboer, M., Manusama, E.R., Marijnen, C.A.M., Nagtegaal, I.D., Peeters, K.C.M.J., Tollenaar, R.A.E.M., van de Velde, C.J.H., Wagner, A., Westerterp, M., van Westreenen, H.L.

“…Transanal total mesorectal excision (TaTME) is a relatively new and demanding technique for rectal cancer treatment. Results from national datasets are absent…”
Get full text

C‐reactive protein (CRP) trajectory as a predictor of anastomotic leakage after rectal cancer resection: A multicentre cohort study by Hoek, Vincent T., Sparreboom, Cloë L., Wolthuis, Albert M., Menon, Anand G., Kleinrensink, Gert‐Jan, D'Hoore, André, Komen, Niels, Lange, Johan F., van Westreenen, H.L., Doornebosch, P.G., Dekker, J.W.T., Daams, F, Lips, D. J., van Grevenstein, W.M.U., Karsten, T.M.

“…Aim This study aimed to identify whether CRP‐trajectory measurement, including increase in CRP‐level of 50 mg/l per day, is an accurate predictor of…”
Get full text

Nationwide analysis of hospital variation in preoperative radiotherapy use for rectal cancer following guideline revision by Detering, Robin, de Neree tot Babberich, Michael P.M., Bos, Amanda C.R.K., Dekker, Jan Willem T., Wouters, Michel W.J.M., Bemelman, Willem A., Beets-Tan, Regina G.H., Marijnen, Corrie A.M., Hompes, Roel, Tanis, Pieter J., Aalbers, A.G.J., den Boer, F.C., Breukink, S., Coene, P.P.L.O., Doornebosch, P.G., Gelderblom, H., Karsten, T.M., Ledeboer, M., Manusama, E.R., Nagtegaal, I.D., Peeters, K.C.M.J., Tollenaar, R.A.E.M., van de Velde, C.J.H., Wagner, A., Westerterp, M., van Westreenen, H.L.

“…The revised Dutch colorectal cancer guideline (2014), led to an overall decrease in preoperative radiotherapy (RT) use. This study evaluates hospital variation…”
Get full text

Laparoscopic versus open pancreatoduodenectomy (LEOPARD-2): a multicenter patient-blinded, randomized controlled trial by van Hilst, J., de Rooij, T., Gerhards, M.F., de Hingh, I.H., Karsten, T.M., Lips, D.J., Luyer, M.D., Busch, O.R.C., Festen, S., Besselink, M.

Get full text

Nationwide Outcome of Gastrectomy with En-Bloc Partial Pancreatectomy for Gastric Cancer by van der Werf, L. R., Eshuis, W. J., Draaisma, W. A., van Etten, B., Gisbertz, S. S., van der Harst, E., Liem, M. S. L., Lemmens, V. E. P. P., Wijnhoven, B. P. L., Besselink, M. G., van Berge Henegouwen, M. I.

“…Background Radical gastrectomy is the cornerstone of the treatment of gastric cancer. For tumors invading the pancreas, en-bloc partial pancreatectomy may be…”
Get full text

Treatment of colorectal anastomotic leakage: results of a questionnaire amongst members of the Dutch Society of Gastrointestinal Surgery by Daams, F, Slieker, J C, Tedja, A, Karsten, T M, Lange, J F

“…Anastomotic leakage after colorectal surgery is correlated with considerable morbidity and mortality. Although many studies focus on risk factors and…”
Get more information

Results of surgery for perforated gastroduodenal ulcers in a Dutch population by Hemmer, P H J, de Schipper, J S, van Etten, B, Pierie, J P E N, Bonenkamp, J J, de Graaf, P W, Karsten, T M

“…Despite improvements in anesthesiology and intensive care medicine, mortality for perforated gastroduodenal ulcer disease remains high. This study was designed…”
Get more information